KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Total Liabilities (2016 - 2025)

Chemed (CHE) has 17 years of Total Liabilities data on record, last reported at $558.8 million in Q4 2025.

  • For Q4 2025, Total Liabilities rose 1.67% year-over-year to $558.8 million; the TTM value through Dec 2025 reached $558.8 million, up 1.67%, while the annual FY2025 figure was $558.8 million, 1.67% up from the prior year.
  • Total Liabilities reached $558.8 million in Q4 2025 per CHE's latest filing, up from $546.9 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $719.4 million in Q4 2021 and bottomed at $513.0 million in Q2 2021.
  • Average Total Liabilities over 5 years is $568.9 million, with a median of $548.3 million recorded in 2024.
  • Peak YoY movement for Total Liabilities: surged 34.8% in 2021, then dropped 14.48% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $719.4 million in 2021, then decreased by 10.58% to $643.3 million in 2022, then decreased by 12.91% to $560.2 million in 2023, then fell by 1.9% to $549.6 million in 2024, then grew by 1.67% to $558.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $558.8 million in Q4 2025, $546.9 million in Q3 2025, and $519.4 million in Q2 2025.